Cargando…
Monitoring and comorbidities in patients with chronic hepatitis B currently treated with nucleos(t)ide analogs
BACKGROUND: Long-term monotherapy with nucleos(t)ide analogs (NAs) represents the treatment option for the majority of patients with chronic hepatitis B (CHB), an aging population with a greater likelihood of comorbidities. We assessed the prevalence of concurrent non-hepatic diseases and the safety...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774663/ https://www.ncbi.nlm.nih.gov/pubmed/33414625 http://dx.doi.org/10.20524/aog.2020.0525 |